The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

In this new video, pediatric cardiologists discuss some of the long-term issues associated with multisystem inflammatory syndrome in children (MIS-C), a rare disease linked to COVID-19.

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

Samuel Jones, MD, examines the large reimbursement reductions in cardiac ablations and what the impact might be on access to care in EP labs.

Advanced cardiac imager Roosha Parikh, MD, explained that cardiac amyloidosis is regularly misdiagnosed. It can often be identified in echocardiography results, however, if physicians know how to identify it. 

Atul Verma, MD, director of cardiology at McGill University Health Centre in Montreal, explained why the late-breaking PULSED-AF trial data on Medtronic’s pulsed-field ablation technology is so important for cardiologists. 

Ashish Sarraju, MD, a cardiologist with Cleveland Clinic, discussed his recent research on ChatGPT, its potential to change patient care and more. 

James Kirkpatrick, MD, discussed some of the biggest trends and themes he saw at the American Society of Echocardiography's 2023 annual meeting.

Paul Sorajja, MD, discusses the late-breaking TRILUMINATE pivotal trial at ACC.23 and how tricuspid TEER performed against the current standard of care using medical therapy.

SCAI President Sunil Rao, MD, spoke with us about some of the key interventional cardiology studies presented at ACC.23 in New Orleans. 

Marcelo DiCarli, MD, and Rob Beanlands, MD, shared their thoughts on the current state of cardiac imaging at ACC.23. 

Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview. 

Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.

To reduce the healthcare costs associated with straightforward, minimally invasive cardiovascular procedures, more and more ambulatory surgical centers and office based labs are opening all over the United States.

Ted Abraham, MD, explained why HCM has entered the limelight at recent cardiology conferences, including ASE 2023.

Cardiac CT has been evolving rapidly in recent years. Brian Ghoshhajra, MD, outlined some of the main trends he has seen at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography.

Most FDA-cleared AI algorithms are related to radiology and cardiology, meaning radiologists and cardiologists need to make an effort to learn how these technologies work.

Pioneering cardiologist James Muller, MD, a winner of the Nobel Peace Prize, was one of the chief researchers that developed the concept of vulnerable plaques causing heart attacks. He was recently honored by the American College of Cardiology for his contributions.

Kenneth Ellenbogen, MD, detailed some of the biggest trends he saw at the three-day event in New Orleans.